2004
DOI: 10.1007/s00216-003-2267-5
|View full text |Cite
|
Sign up to set email alerts
|

Determination of a flame retardant hydrolysis product in human urine by SPE and LC?MS. Comparison of molecularly imprinted solid-phase extraction with a mixed-mode anion exchanger

Abstract: Diphenyl phosphate is a hydrolysis product and possible metabolite of the flame retardant and plasticiser additive triphenyl phosphate. A molecularly imprinted polymer solid-phase extraction (MISPE) method for extracting diphenyl phosphate from aqueous solutions has been developed and compared with SPE using a commercially available mixed-mode anion exchanger. The imprinted polymer was prepared using 2-vinylpyridine (2-Vpy) as the functional monomer, ethylene glycol dimethacrylate (EGDMA) as the cross-linker, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(21 citation statements)
references
References 26 publications
(29 reference statements)
2
19
0
Order By: Relevance
“…Recently, quantified DAPs and MAPs in urine have been identified as biomarkers to assess human exposure. In total, DAPs of BDCIPP, BCIPP, BCEP, BBOEP, DBP, DPHP, DEHP and some MAPs of MEHP, MBP, MCIPP, MBOEP and MPHP have been quantified in human urine, with median concentrations in the ng ml À1 range (Butt et al, 2014;Cequier et al, 2014bCequier et al, , 2015Chu et al, 2011;Cooper et al, 2011;Dodson et al, 2014;Fromme et al, 2014;Hoffman et al, 2015;Meeker et al, 2013a,b;Moller et al, 2004;Petropoulou et al, 2016;Reemtsma et al, 2011;Schindler et al, 2009a,b;Van den Eede et al, 2015b;Van den Eede et al, 2013b) (SI Table S2). However, no information is available for DAPs and MAPs or other OPFR metabolites from internal exposure studies of wild animals.…”
Section: Internal Exposurementioning
confidence: 99%
“…Recently, quantified DAPs and MAPs in urine have been identified as biomarkers to assess human exposure. In total, DAPs of BDCIPP, BCIPP, BCEP, BBOEP, DBP, DPHP, DEHP and some MAPs of MEHP, MBP, MCIPP, MBOEP and MPHP have been quantified in human urine, with median concentrations in the ng ml À1 range (Butt et al, 2014;Cequier et al, 2014bCequier et al, , 2015Chu et al, 2011;Cooper et al, 2011;Dodson et al, 2014;Fromme et al, 2014;Hoffman et al, 2015;Meeker et al, 2013a,b;Moller et al, 2004;Petropoulou et al, 2016;Reemtsma et al, 2011;Schindler et al, 2009a,b;Van den Eede et al, 2015b;Van den Eede et al, 2013b) (SI Table S2). However, no information is available for DAPs and MAPs or other OPFR metabolites from internal exposure studies of wild animals.…”
Section: Internal Exposurementioning
confidence: 99%
“…These metabolites in human biological fluids, such as urine, therefore, may serve as biomarkers of human exposure to their parent FRs. No methods currently exist to measure BDCPP in human biological fluids or tissues, however, there are a few published methods to measure DPP in human urine [1719]. …”
Section: Introductionmentioning
confidence: 99%
“…2). Such MIPs are hence analogous to polyclonal antibodies and are sometimes "group-specific," that is, selective not only towards the original template but also to other structurally related compounds, which can be quite useful, for example, for the separation of a class of analytes [13]. After polymerization, the Fig.…”
Section: Imprinting Matricesmentioning
confidence: 99%